Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04735978
Title Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Replimune Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GRC | GBR | FRA | ESP

Facility Status City State Zip Country Details
University of Iowa Iowa City Iowa 52242 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Laboratoire de Recherche Translationnelle en Immunotherapie (LRTI), Gustave Roussy Villejuif 94805 France Details
University of Athens Athens 11527 Greece Details
University General Hospital Attikon Athens 12462 Greece Details
Vall d'Hebron Hospital Hospital Universitario Vall d´Hebron (Vall d'Hebron University Hospital) Barcelona 08035 Spain Details
Hospital Clinic Barcelona Barcelona 08036 Spain Details
START Madrid CIO Clara Campal, Hospital Universitario HM Sanchinarro Unidad de Ensayos Fase I Panta 3 Madrid 28050 Spain Details
Hospital Clinico Universitario de Valencia Valencia 46010 Spain Details
The Clatterbridge Cancer Centre NHS Foundation Trust Bebington Merseyside CH63 4JY United Kingdom Details
The Royal Marsden NHS Foundation Trust London SW3 6JJ United Kingdom Details
Churchill Hospital Oxford OX3 9DU United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field